168 related articles for article (PubMed ID: 30197330)
1. Immunohistochemical study of the expression of human chorionic gonadotropin-β in salivary gland tumors.
Meda S; Reginald BA; Reddy BS
J Cancer Res Ther; 2018; 14(5):952-956. PubMed ID: 30197330
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
[TBL] [Abstract][Full Text] [Related]
4. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
5. [Determination of DNA content in salivary gland tumors].
Yáñez M; Roa I; Villaseca M; Fuentealba P
Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
Toper MH; Sarioglu S
Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
[TBL] [Abstract][Full Text] [Related]
7. Expression of ras-P21 in salivary gland tumors.
Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
[No Abstract] [Full Text] [Related]
8. Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation.
Jaafari-Ashkavandi Z; Ashraf MJ; Abbaspoorfard AA
Braz J Otorhinolaryngol; 2019; 85(2):144-149. PubMed ID: 29339028
[TBL] [Abstract][Full Text] [Related]
9. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.
Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Okamura K; Komatsu S; Rasul AM; Sakai H
Oral Oncol; 2001 Apr; 37(3):315-22. PubMed ID: 11287288
[TBL] [Abstract][Full Text] [Related]
11. TGFβ signaling pathway in salivary gland tumors.
Gomes ÁNM; Oliveira KK; Marchi FA; Bettim BB; Germano JN; Gonçalves Filho J; Pinto CAL; Lourenço SV; Coutinho-Camillo CM
Arch Oral Biol; 2024 Jun; 162():105943. PubMed ID: 38479278
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
13. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
15. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
[TBL] [Abstract][Full Text] [Related]
16. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of SIX1, ME2, and AP2M1 in adenoid cystic carcinoma and mucoepidermoid carcinoma.
Wu CC; Li H; Xiao Y; Deng WW; Sun ZJ
Oral Dis; 2020 Nov; 26(8):1687-1695. PubMed ID: 32564485
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
19. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
Stenman G
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
[TBL] [Abstract][Full Text] [Related]
20. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]